マルチオミクスサービスの世界市場：市場規模・シェア・動向分析 (サービス別・種類別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2033年)

マルチオミクスサービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマルチオミクスサービスの市場規模は2033年までに47億2,000万米ドルに達し、2025年から2033年までのCAGRは17.41％で成長すると予測されています。

マルチオミクスサービス業界は、精密医療、高度診断、システム生物学研究を可能にする統合された生物学的データに対する需要の高まりによって、加速度的な成長を目の当たりにしています。複雑な生物学的メカニズムを理解する必要性が高まるにつれ、ゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクス、エピゲノミクスを組み合わせたマルチオミクス・アプローチは、包括的なバイオマーカー探索、疾患層別化、治療開発にとって不可欠なツールになりつつあります。

製薬企業やバイオテクノロジー企業、研究機関、臨床研究所は、疾患経路、治療標的、患者固有の反応についてより深い洞察を得るために、マルチオミクス・プラットフォームの活用をますます進めています。戦略的提携、研究開発投資の増加、技術的融合は、マルチオミクスサービスの革新を促進し、同時に多様なオミクス層にわたるデータ統合と解釈可能性を向上させています。

腫瘍学、免疫学、神経学、感染症研究におけるマルチオミクスの採用拡大が、市場の拡大をさらに後押ししています。データの品質、プライバシー、臨床検証に関する規制の枠組みが強化される中、サービスプロバイダーは、進化する顧客ニーズやコンプライアンスニーズに対応するため、堅牢な品質管理システム、安全なデータ管理ソリューション、AI主導の分析に投資しています。マルチオミクスサービスは、生物学的システムと疾患進行の全体像を提供することで、トランスレーショナルメディスンと個別化医療の未来を再構築しています。

オミックス技術の急速な進化と精密な洞察に対する需要の高まりにより、マルチオミクスサービス市場は次世代の生物医学革新と世界の健康変革の礎石となる位置づけにあります。

マルチオミクスサービス市場：分析概要

• 2024年の市場収益シェアは研究サービス分野が最大でした。このリーダーシップは、前臨床試験、メカニズム研究、早期創薬をサポートする基礎的役割に由来します。マルチオミクスアプローチが複雑な疾患生物学を理解するために不可欠になるにつれ、学術的・商業的な研究需要は増加の一途をたどっています。
• バルクマルチオミクスのセグメントが2024年に最大の市場収益シェアを占めたのは、大規模研究に広く採用され、ゲノミクス、トランスクリプトミクス、プロテオミクスのワークフローが確立されたためです。これらのアプローチは、集団レベルのバイオマーカー探索、疾患プロファイリング、標的バリデーションに広く利用されています。シングルセルシーケンス技術の進歩は、腫瘍学、免疫学、神経科学の研究分野での採用を促進し続けています。
• 創薬・医薬品開発セグメントは、標的同定を加速し研究開発を合理化するための統合データへのニーズの高まりに牽引され、2024年に35.45%の最大売上シェアで市場をリードしました。しかし、合成生物学セグメントは、予測期間中に19.40％のCAGRで最速の成長が見込まれています。
• 製薬・バイオテクノロジー分野は、2024年に最大の市場収益シェアを占めました。これらの組織は、精密医薬品開発、コンパニオン診断、治療最適化を加速するために、研究開発ワークフローにマルチオミクスを組み込んでいます。CRO（医薬品開発業務受託機関）やマルチオミクスプラットフォームプロバイダーとの共同研究の増加が、このセグメントを支えています。
• 北米が2024年に40.13%の最大収益シェアで市場を独占しました。これは、高度な医療インフラ、強力なゲノム研究資金、オミックス技術の早期導入に起因します。しかし、アジア太平洋地域は予測期間中に19.62%という最高のCAGRで成長すると予測されています。
• 2025年1月、エヌビディアはIQVIA、イルミナ、メイヨークリニック、アーク研究所との戦略的パートナーシップを発表し、ゲノミクス、創薬、医療に革命を起こします。この取り組みは、臨床試験を迅速化するAIエージェント、創薬とデジタル病理学のためのAIモデル、手術と患者モニタリングのための物理的AIロボットの開発に重点を置いています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• マルチオミクスサービス市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 マルチオミクスサービス市場：サービス別のビジネス分析

• セグメントダッシュボード：サービス別
• 世界のマルチオミクスサービス市場：変動分析、サービス別
• 世界のマルチオミクスサービスの市場規模と動向分析：サービス別（2021～2033年）
• 研究サービス
• データ分析サービス

第5章 マルチオミクスサービス市場：種類別のビジネス分析

• セグメントダッシュボード：種類別
• 世界のマルチオミクスサービス市場：変動分析、種類別
• 世界のマルチオミクスサービスの市場規模と動向分析：種類別（2021～2033年）
• 単細胞マルチオミクス
• バルクマルチオミクス

第6章 マルチオミクスサービス市場：用途別のビジネス分析

• セグメントダッシュボード：用途別
• 世界のマルチオミクスサービス市場：変動分析、用途別
• 世界のマルチオミクスサービスの市場規模と動向分析：用途別（2021～2033年）
• バイオマーカー発見
• 創薬・薬剤開発
• 合成生物学
• その他

第7章 マルチオミクスサービス市場：最終用途別のビジネス分析

• セグメントダッシュボード：最終用途別
• 世界のマルチオミクスサービス市場：変動分析、最終用途別
• 世界のマルチオミクスサービスの市場規模と動向分析：最終用途別（2021～2033年）
• 製薬・バイオテクノロジー企業
• 学術研究機関
• その他

第8章 マルチオミクスサービス市場：地域別の推定・動向分析

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析（2024年）
• 企業プロファイル/上場企業
  • Bio-Techne
  • CD Genomics
  • RayBiotech, Inc.
  • . Creative Proteomics
  • Psomagen
  • Source BioScience
  • Persistent Systems
  • Metware Biotechnology Inc.
  • Dalton Bioanalytics Inc.
  • Sapient Bioanalytics, LLC.

List of Tables

• Table 1 North America multiomics services market estimates & forecasts
• Table 2 North America multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 3 North America multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 4 North America multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 5 North America multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 6 U.S. multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 7 U.S. multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 8 U.S. multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 9 U.S. multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 10 Canada multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 11 Canada multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 12 Canada multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 13 Canada multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 14 Mexico multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 15 Mexico multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 16 Mexico multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 17 Mexico multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 18 Europe multiomics services market estimates & forecasts
• Table 19 Europe multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 20 Europe multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 21 Europe multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 22 Europe multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 23 UK multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 24 UK multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 25 UK multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 26 UK multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 27 Germany multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 28 Germany multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 29 Germany multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 30 Germany multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 31 France multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 32 France multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 33 France multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 34 France multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 35 Spain multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 36 Spain multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 37 Spain multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 38 Spain multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 39 Italy multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 40 Italy multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 41 Italy multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 42 Italy multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 43 Denmark multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 44 Denmark multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 45 Denmark multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 46 Denmark multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 47 Sweden multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 48 Sweden multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 49 Sweden multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 50 Sweden multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 51 Norway multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 52 Norway multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 53 Norway multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 54 Norway multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 55 Asia Pacific multiomics services market estimates & forecasts
• Table 56 Asia Pacific multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 57 Asia Pacific multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 58 Asia Pacific multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 59 Asia Pacific multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 60 China multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 61 China multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 62 China multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 63 China multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 64 Japan multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 65 Japan multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 66 Japan multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 67 Japan multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 68 India multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 69 India multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 70 India multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 71 India multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 72 South Korea multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 73 South Korea multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 74 South Korea multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 75 South Korea multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 76 Australia multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 77 Australia multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 78 Australia multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 79 Australia multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 80 Thailand multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 81 Thailand multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 82 Thailand multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 83 Thailand multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 84 Latin America multiomics services market estimates & forecasts
• Table 85 Latin America multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 86 Latin America multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 87 Latin America multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 88 Latin America multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 89 Brazil multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 90 Brazil multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 91 Brazil multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 92 Brazil multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 93 Argentina multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 94 Argentina multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 95 Argentina multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 96 Argentina multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 97 MEA multiomics services market estimates & forecasts
• Table 98 MEA multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 99 MEA multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 100 MEA multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 101 MEA multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 102 South Africa multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 103 South Africa multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 104 South Africa multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 105 South Africa multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 106 Saudi Arabia multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 107 Saudi Arabia multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 108 Saudi Arabia multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 109 Saudi Arabia multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 110 UAE multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 111 UAE multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 112 UAE multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 113 UAE multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
• Table 114 Kuwait multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 115 Kuwait multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 116 Kuwait multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 117 Kuwait multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 Participant categorization
• Fig. 14 Multiomics Services market: Service outlook key takeaways
• Fig. 15 Multiomics Services market: Service movement analysis
• Fig. 16 Research Services market, 2021 - 2033 (USD million)
• Fig. 17 Data Analysis Services market, 2021 - 2033 (USD million)
• Fig. 18 Multiomics Services market: Type outlook key takeaways
• Fig. 19 Multiomics Services market: Type movement analysis
• Fig. 20 Single-cell Multiomics market, 2021 - 2033 (USD million)
• Fig. 21 Bulk Multiomics market, 2021 - 2033 (USD million)
• Fig. 22 Multiomics Services market: Application outlook key takeaways
• Fig. 23 Multiomics Services market: Application movement analysis
• Fig. 24 Biomarker Discovery market, 2021 - 2033 (USD million)
• Fig. 25 Drug Discovery & Development market, 2021 - 2033 (USD million)
• Fig. 26 Synthetic Biology market, 2021 - 2033 (USD million)
• Fig. 27 Others market, 2021 - 2033 (USD million)
• Fig. 28 Multiomics Services market: End Use outlook key takeaways
• Fig. 29 Multiomics Services market: End Use movement analysis
• Fig. 30 Academic & Research Institutes market, 2021 - 2033 (USD Million)
• Fig. 31 Pharmaceutical and Biotechnology Companies market, 2021 - 2033 (USD Million)
• Fig. 32 Others market, 2021 - 2033 (USD Million)
• Fig. 33 Multiomics Services market, by region, 2021 - 2033 (USD Million)
• Fig. 34 North America multiomics services market, by country, 2021 - 2033 (USD Million)
• Fig. 35 U.S. multiomics services market, 2021 - 2033 (USD Million)
• Fig. 36 Canada multiomics services market, 2021 - 2033 (USD Million)
• Fig. 37 Mexico multiomics services market, 2021 - 2033 (USD Million)
• Fig. 38 Europe multiomics services market, by country, 2021 - 2033 (USD Million)
• Fig. 39 UK multiomics services market, 2021 - 2033 (USD Million)
• Fig. 40 Germany multiomics services market, 2021 - 2033 (USD Million)
• Fig. 41 France multiomics services market, 2021 - 2033 (USD Million)
• Fig. 42 Italy multiomics services market, 2021 - 2033 (USD Million)
• Fig. 43 Spain multiomics services market, 2021 - 2033 (USD Million)
• Fig. 44 Denmark multiomics services market, 2021 - 2033 (USD Million)
• Fig. 45 Sweden multiomics services market, 2021 - 2033 (USD Million)
• Fig. 46 Norway multiomics services market, 2021 - 2033 (USD Million)
• Fig. 47 Asia Pacific multiomics services market, by country, 2021 - 2033 (USD Million)
• Fig. 48 Japan multiomics services market, 2021 - 2033 (USD Million)
• Fig. 49 China multiomics services market, 2021 - 2033 (USD Million)
• Fig. 50 India multiomics services market, 2021 - 2033 (USD Million)
• Fig. 51 Australia multiomics services market, 2021 - 2033 (USD Million)
• Fig. 52 South Korea multiomics services market, 2021 - 2033 (USD Million)
• Fig. 53 Thailand multiomics services market, 2021 - 2033 (USD Million)
• Fig. 54 Latin America multiomics services market, by country, 2021 - 2033 (USD Million)
• Fig. 55 Brazil multiomics services market, 2021 - 2033 (USD Million)
• Fig. 56 Argentina multiomics services market, 2021 - 2033 (USD Million)
• Fig. 57 Middle East & Africa multiomics services market, by country, 2021 - 2033 (USD Million)
• Fig. 58 South Africa multiomics services market, 2021 - 2033 (USD Million)
• Fig. 59 Saudi Arabia multiomics services market, 2021 - 2033 (USD Million)
• Fig. 60 UAE multiomics services market, 2021 - 2033 (USD Million)
• Fig. 61 Kuwait multiomics services market, 2021 - 2033 (USD Million)
• Fig. 62 Key companies profiled

Multiomics Services Market Growth & Trends:

The global multiomics services market size is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 17.41% from 2025 to 2033, according to a new report by Grand View Research, Inc. The multiomics services industry is witnessing accelerated growth, driven by the increasing demand for integrated biological data to enable precision medicine, advanced diagnostics, and systems biology research. As the need to understand complex biological mechanisms intensifies, multiomics approaches combining genomics, transcriptomics, proteomics, metabolomics, and epigenomics are becoming essential tools for comprehensive biomarker discovery, disease stratification, and therapeutic development.

Pharmaceutical and biotechnology companies, research institutions, and clinical laboratories increasingly leverage multiomics platforms to gain deeper insights into disease pathways, therapeutic targets, and patient-specific responses. Strategic collaborations, rising R&D investments, and technological convergence catalyze innovation in multiomics service offerings while enhancing data integration and interpretability across diverse omics layers.

The growing adoption of multiomics in oncology, immunology, neurology, and infectious disease research further fueled the market's expansion. As regulatory frameworks around data quality, privacy, and clinical validation tighten, service providers invest in robust quality control systems, secure data management solutions, and AI-driven analytics to meet evolving customer and compliance needs. Multiomics services are reshaping the future of translational medicine and individualized healthcare by offering holistic views of biological systems and disease progression.

With the rapid evolution of omics technologies and the growing demand for precision insights, the multiomics services market is positioned to become a cornerstone of next-generation biomedical innovation and global health transformation.

Multiomics Services Market Report Highlights:

• The research services segment accounted for the largest market revenue share in 2024. This leadership derives from their foundational role in supporting preclinical studies, mechanistic research, and early-stage drug discovery. As multiomics approaches become integral to understanding complex disease biology, academic and commercial research demand continues to rise.
• The bulk multiomics segment accounted for the largest market revenue share in 2024, owing to its widespread adoption in large-scale studies and established workflows in genomics, transcriptomics, and proteomics. These approaches are widely used in population-level biomarker discovery, disease profiling, and target validation. Advances in single cell sequencing technologies continue to drive adoption across oncology, immunology, and neuroscience research.
• The drug discovery & development segment led the market with the largest revenue share of 35.45% in 2024, driven by the growing need for integrated data to accelerate target identification and streamline R&D. However, the synthetic biology segment is expected to grow at the fastest CAGR of 19.40% over the forecast period.
• The pharmaceutical and biotechnology segment accounted for the largest market revenue share in 2024. These organizations integrate multiomics into R&D workflows to accelerate precision drug development, companion diagnostics, and therapeutic optimization. Increasing collaborations with contract research organizations (CROs) and multiomics platform providers support this segment.
• North America dominated the market with the largest revenue share of 40.13% in 2024. This is attributed to advanced healthcare infrastructure, strong genomics research funding, and early adoption of omics technologies. However, Asia Pacific is expected to grow at the highest CAGR of 19.62% over the forecast period.
• In January 2025, NVIDIA announced strategic partnerships with IQVIA, Illumina, Mayo Clinic, and Arc Institute to revolutionize genomics, drug discovery, and healthcare. The initiatives focus on developing AI agents to expedite clinical trials, AI models for drug discovery and digital pathology, and physical AI robots for surgery and patient monitoring.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Service Segment
  • 1.2.2. Type Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Multiomics Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Services Market: Service Business Analysis

• 4.1. Service Segment Dashboard
• 4.2. Global Multiomics Services Market Service Movement Analysis
• 4.3. Global Multiomics Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
• 4.4. Research Services
  • 4.4.1. Global Research Services based Market, 2021 - 2033 (USD Million)
• 4.5. Data Analysis Services
  • 4.5.1. Global Data Analysis Services Market, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Services Market: Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Multiomics Services Market Type Movement Analysis
• 5.3. Global Multiomics Services Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Single-cell Multiomics
  • 5.4.1. Global Single-cell Multiomics Market, 2021 - 2033 (USD Million)
• 5.5. Bulk Multiomics
  • 5.5.1. Global Bulk Multiomics Market, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Services Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Multiomics Services Market Application Movement Analysis
• 6.3. Global Multiomics Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Biomarker Discovery Market
  • 6.4.1. Global Biomarker Discovery Market, 2021 - 2033 (USD Million)
• 6.5. Drug Discovery & Development
  • 6.5.1. Global Drug Discovery & Development Market, 2021 - 2033 (USD Million)
• 6.6. Synthetic Biology
  • 6.6.1. Global Synthetic Biology Market, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Services Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Multiomics Services Market End Use Movement Analysis
• 7.3. Global Multiomics Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical and Biotechnology Companies
  • 7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2021 - 2033 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Global Academic & Research Institutes Market, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Multiomics Services Market: Region Estimates & Trend Analysis

• 8.1. North America
  • 8.1.1. North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.1.2. U.S.
    • 8.1.2.1. Key country dynamics
    • 8.1.2.2. Competitive scenario
    • 8.1.2.3. Regulatory Framework
    • 8.1.2.4. Target Disease Prevalence
    • 8.1.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.1.3. Canada
    • 8.1.3.1. Key country dynamics
    • 8.1.3.2. Competitive scenario
    • 8.1.3.3. Regulatory Framework
    • 8.1.3.4. Target Disease Prevalence
    • 8.1.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.1.4. Mexico
    • 8.1.4.1. Key country dynamics
    • 8.1.4.2. Competitive scenario
    • 8.1.4.3. Regulatory Framework
    • 8.1.4.4. Target Disease Prevalence
    • 8.1.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.2. Europe
  • 8.2.1. Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.2. UK
    • 8.2.2.1. Key country dynamics
    • 8.2.2.2. Competitive scenario
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. Target Disease Prevalence
    • 8.2.2.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.3. Germany
    • 8.2.3.1. Key country dynamics
    • 8.2.3.2. Competitive scenario
    • 8.2.3.3. Regulatory Framework
    • 8.2.3.4. Target Disease Prevalence
    • 8.2.3.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.4. France
    • 8.2.4.1. Key country dynamics
    • 8.2.4.2. Competitive scenario
    • 8.2.4.3. Regulatory Framework
    • 8.2.4.4. Target Disease Prevalence
    • 8.2.4.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.5. Italy
    • 8.2.5.1. Key country dynamics
    • 8.2.5.2. Competitive scenario
    • 8.2.5.3. Regulatory Framework
    • 8.2.5.4. Target Disease Prevalence
    • 8.2.5.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.6. Spain
    • 8.2.6.1. Key country dynamics
    • 8.2.6.2. Competitive scenario
    • 8.2.6.3. Regulatory Framework
    • 8.2.6.4. Target Disease Prevalence
    • 8.2.6.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.7. Norway
    • 8.2.7.1. Key country dynamics
    • 8.2.7.2. Competitive scenario
    • 8.2.7.3. Regulatory Framework
    • 8.2.7.4. Target Disease Prevalence
    • 8.2.7.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.8. Sweden
    • 8.2.8.1. Key country dynamics
    • 8.2.8.2. Competitive scenario
    • 8.2.8.3. Regulatory Framework
    • 8.2.8.4. Target Disease Prevalence
    • 8.2.8.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2.9. Denmark
    • 8.2.9.1. Key country dynamics
    • 8.2.9.2. Competitive scenario
    • 8.2.9.3. Regulatory Framework
    • 8.2.9.4. Target Disease Prevalence
    • 8.2.9.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.3. Asia Pacific
  • 8.3.1. Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. Japan
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Target Disease Prevalence
    • 8.3.2.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. China
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Target Disease Prevalence
    • 8.3.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. India
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Target Disease Prevalence
    • 8.3.4.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.5. Thailand
    • 8.3.5.1. Key country dynamics
    • 8.3.5.2. Competitive scenario
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Target Disease Prevalence
    • 8.3.5.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.6. South Korea
    • 8.3.6.1. Key country dynamics
    • 8.3.6.2. Competitive scenario
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. Target Disease Prevalence
    • 8.3.6.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.7. Australia
    • 8.3.7.1. Key country dynamics
    • 8.3.7.2. Competitive scenario
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Target Disease Prevalence
    • 8.3.7.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Latin America
  • 8.4.1. Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. Brazil
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Target Disease Prevalence
    • 8.4.2.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Argentina
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Target Disease Prevalence
    • 8.4.3.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Middle East & Africa
  • 8.5.1. Middle East & Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. South Africa
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Target Disease Prevalence
    • 8.5.2.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Saudi Arabia
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Target Disease Prevalence
    • 8.5.3.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. UAE
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Target Disease Prevalence
    • 8.5.4.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Kuwait
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Target Disease Prevalence
    • 8.5.5.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Bio-Techne
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Service Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. CD Genomics
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Service Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. RayBiotech, Inc.
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Service Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. . Creative Proteomics
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Service Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Psomagen
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Service Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Source BioScience
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Service Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Persistent Systems
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Service Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Metware Biotechnology Inc.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Service Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Dalton Bioanalytics Inc.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Service Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Sapient Bioanalytics, LLC.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Service Benchmarking
    • 9.4.10.4. Strategic Initiatives